Compugroup Medical Financials
| COP Stock | EUR 15.86 0.33 2.04% |
Compugroup |
Understanding current and past Compugroup Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Compugroup Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Compugroup Medical's assets may result in an increase in income on the income statement.
Compugroup Medical Stock Summary
Compugroup Medical competes with Superior Plus, NMI Holdings, Origin Agritech, SIVERS SEMICONDUCTORS, and NorAm Drilling. CompuGroup Medical Societas Europaea develops and sells software and information technology services for healthcare sector worldwide. CompuGroup Medical Societas Europaea was founded in 1979 and is headquartered in Koblenz, Germany. COMPUGROUP MED operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 5000 people.| Foreign Associate | USA |
| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | DE000A288904 |
| Business Address | Maria Trost 21, |
| Sector | Technology |
| Industry | Health Information Services |
| Benchmark | Dow Jones Industrial |
| Website | www.cgm.com |
| Phone | 49 261 8000 0 |
| Currency | EUR - Euro |
You should never invest in Compugroup Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Compugroup Stock, because this is throwing your money away. Analyzing the key information contained in Compugroup Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Compugroup Medical Key Financial Ratios
There are many critical financial ratios that Compugroup Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Compugroup Medical reports annually and quarterly.| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Target Price | 51.81 | |||
| Beta | 1.07 | |||
| Z Score | 1.8 |
Compugroup Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Compugroup Medical's current stock value. Our valuation model uses many indicators to compare Compugroup Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Compugroup Medical competition to find correlations between indicators driving Compugroup Medical's intrinsic value. More Info.Compugroup Medical SE is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.29 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Compugroup Medical SE is roughly 3.49 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Compugroup Medical's earnings, one of the primary drivers of an investment's value.Compugroup Medical Systematic Risk
Compugroup Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Compugroup Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Compugroup Medical correlated with the market. If Beta is less than 0 Compugroup Medical generally moves in the opposite direction as compared to the market. If Compugroup Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Compugroup Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Compugroup Medical is generally in the same direction as the market. If Beta > 1 Compugroup Medical moves generally in the same direction as, but more than the movement of the benchmark.
Compugroup Medical Thematic Clasifications
Compugroup Medical SE is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Compugroup Medical December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Compugroup Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Compugroup Medical SE. We use our internally-developed statistical techniques to arrive at the intrinsic value of Compugroup Medical SE based on widely used predictive technical indicators. In general, we focus on analyzing Compugroup Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Compugroup Medical's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.35 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 12.99 | |||
| Value At Risk | (3.38) | |||
| Potential Upside | 4.42 |
Complementary Tools for Compugroup Stock analysis
When running Compugroup Medical's price analysis, check to measure Compugroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugroup Medical is operating at the current time. Most of Compugroup Medical's value examination focuses on studying past and present price action to predict the probability of Compugroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugroup Medical's price. Additionally, you may evaluate how the addition of Compugroup Medical to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |